M

Medicon Hellas SA
ATHEX:MEDIC

Watchlist Manager
Medicon Hellas SA
ATHEX:MEDIC
Watchlist
Price: 2.5 EUR 0.81% Market Closed
Market Cap: €11.1m

Medicon Hellas SA
Investor Relations

Medicon Hellas SA engages in the business of medical technology. The company is headquartered in Athina, Attiki. The company went IPO on 2001-07-11. Its activities include research and development, production, and import and export of diagnostic products; the development of laboratory information systems; the import and distribution of in vitro diagnostics and automated analytical systems, such as Olympus for clinical chemistry, immunochemistry and lab automation, and Nihon Kohden for hematology, and the provision of cosmetic and body care products, such as make-up, anti-ageing and skin care products under the brand name Miss Beaute. Its laboratory information systems products include: Gi-Lab, which is a management system for medical laboratories; Gi-Maxima, a management program for medical centers, and Gi-Blood, which is an application that helps to connect various blood donation networks. On December 6, 2013, it merged by absorption of its subsidiary, Medicon Ltd.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Dimotsantos S. Spyridon
CEO & Chairman of the Board
No Bio Available
Mr. George Kyridis
Chief Financial Officer
No Bio Available
Mr. Georgios Dimotsantos
Deputy CEO & Executive Director
No Bio Available

Contacts

Address
ATTIKI
ATHINA
Melitona 5-7, Gerakas
Contacts
+302106606000.0
www.mediconsa.com